科研製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/02/05 | 5,810 | 5,830 | 5,710 | 5,720 | -190 | -3.2% | 151,500 |
2018/02/02 | 5,840 | 5,950 | 5,800 | 5,910 | +60 | +1% | 166,600 |
2018/02/01 | 5,720 | 5,960 | 5,720 | 5,850 | +130 | +2.3% | 241,300 |
2018/01/31 | 5,770 | 5,790 | 5,710 | 5,720 | -90 | -1.5% | 110,600 |
2018/01/30 | 5,870 | 5,890 | 5,770 | 5,810 | -70 | -1.2% | 168,100 |
2018/01/29 | 5,910 | 5,910 | 5,830 | 5,880 | -30 | -0.5% | 112,600 |
2018/01/26 | 5,950 | 5,980 | 5,900 | 5,910 | +10 | +0.2% | 119,600 |
2018/01/25 | 5,940 | 5,950 | 5,880 | 5,900 | -40 | -0.7% | 66,100 |
2018/01/24 | 5,870 | 5,950 | 5,860 | 5,940 | +70 | +1.2% | 107,100 |
2018/01/23 | 5,850 | 5,880 | 5,830 | 5,870 | +20 | +0.3% | 73,900 |
2018/01/22 | 5,780 | 5,850 | 5,760 | 5,850 | +120 | +2.1% | 104,900 |
2018/01/19 | 5,790 | 5,800 | 5,720 | 5,730 | +30 | +0.5% | 74,700 |
2018/01/18 | 5,810 | 5,840 | 5,680 | 5,700 | -10 | -0.2% | 212,000 |
2018/01/17 | 5,730 | 5,740 | 5,710 | 5,710 | -30 | -0.5% | 85,400 |
2018/01/16 | 5,760 | 5,780 | 5,720 | 5,740 | ±0 | ±0% | 47,600 |
2018/01/15 | 5,820 | 5,820 | 5,720 | 5,740 | -70 | -1.2% | 86,900 |
2018/01/12 | 5,830 | 5,840 | 5,790 | 5,810 | -40 | -0.7% | 104,300 |
2018/01/11 | 5,880 | 5,900 | 5,810 | 5,850 | -40 | -0.7% | 93,700 |
2018/01/10 | 5,910 | 5,920 | 5,860 | 5,890 | -10 | -0.2% | 89,300 |
2018/01/09 | 5,890 | 5,900 | 5,860 | 5,900 | +10 | +0.2% | 75,200 |
2018/01/05 | 5,880 | 5,900 | 5,820 | 5,890 | +10 | +0.2% | 134,200 |
2018/01/04 | 5,880 | 5,910 | 5,830 | 5,880 | +60 | +1% | 147,200 |
2017/12/29 | 5,720 | 5,840 | 5,690 | 5,820 | +120 | +2.1% | 169,700 |
2017/12/28 | 5,680 | 5,740 | 5,680 | 5,700 | -10 | -0.2% | 114,800 |
2017/12/27 | 5,840 | 5,860 | 5,680 | 5,710 | -240 | -4% | 296,200 |
2017/12/26 | 5,920 | 5,980 | 5,900 | 5,950 | +20 | +0.3% | 59,500 |
2017/12/25 | 5,930 | 5,940 | 5,890 | 5,930 | ±0 | ±0% | 54,000 |
2017/12/22 | 5,980 | 6,000 | 5,920 | 5,930 | -60 | -1% | 115,000 |
2017/12/21 | 5,970 | 6,000 | 5,930 | 5,990 | +30 | +0.5% | 149,500 |
2017/12/20 | 5,940 | 5,970 | 5,910 | 5,960 | +10 | +0.2% | 104,900 |
2017/12/19 | 5,910 | 5,950 | 5,900 | 5,950 | +50 | +0.8% | 134,100 |
2017/12/18 | 5,880 | 5,900 | 5,820 | 5,900 | +100 | +1.7% | 136,800 |
2017/12/15 | 5,870 | 5,870 | 5,780 | 5,800 | -40 | -0.7% | 80,700 |
2017/12/14 | 5,900 | 5,910 | 5,800 | 5,840 | -40 | -0.7% | 107,900 |
2017/12/13 | 5,850 | 5,940 | 5,820 | 5,880 | +60 | +1% | 164,100 |
2017/12/12 | 5,780 | 5,840 | 5,780 | 5,820 | +50 | +0.9% | 122,800 |
2017/12/11 | 5,760 | 5,780 | 5,720 | 5,770 | +50 | +0.9% | 108,400 |
2017/12/08 | 5,620 | 5,720 | 5,610 | 5,720 | +60 | +1.1% | 195,200 |
2017/12/07 | 5,600 | 5,680 | 5,600 | 5,660 | +100 | +1.8% | 97,800 |
2017/12/06 | 5,640 | 5,650 | 5,550 | 5,560 | -100 | -1.8% | 132,300 |
2017/12/05 | 5,650 | 5,690 | 5,640 | 5,660 | -20 | -0.4% | 119,400 |
2017/12/04 | 5,710 | 5,770 | 5,660 | 5,680 | -30 | -0.5% | 157,000 |
2017/12/01 | 5,690 | 5,730 | 5,640 | 5,710 | +90 | +1.6% | 234,900 |
2017/11/30 | 5,550 | 5,660 | 5,550 | 5,620 | +80 | +1.4% | 363,100 |
2017/11/29 | 5,540 | 5,560 | 5,500 | 5,540 | +20 | +0.4% | 183,000 |
2017/11/28 | 5,490 | 5,540 | 5,480 | 5,520 | +30 | +0.5% | 127,800 |
2017/11/27 | 5,570 | 5,580 | 5,470 | 5,490 | -60 | -1.1% | 215,200 |
2017/11/24 | 5,650 | 5,660 | 5,500 | 5,550 | -130 | -2.3% | 269,800 |
2017/11/22 | 5,810 | 5,820 | 5,670 | 5,680 | -90 | -1.6% | 132,700 |
2017/11/21 | 5,750 | 5,800 | 5,750 | 5,770 | +20 | +0.3% | 79,800 |
1801~
1850
件表示中 / 3725件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
科研薬 | 384,400円 | -6.4% | -71.8% | 4.94% | 42.94倍 | 0.96倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 376,500円 | +21.7% | +999.9% | 0.00% | 15.77倍 | 5.22倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がTOB実施 |
東和薬品 | 295,300円 | +7.9% | -3.3% | 2.71% | 8.21倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 204,800円 | +3.1% | -6.5% | 2.34% | 9.50倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム